IP Library Granted Patent US 10,240,191
Granted Patent B2
US 10,240,191 · App. 15/803,609 · Granted Mar 26, 2019

Amplification and detection of ribonucleic acids

Inventor: R. Scott Kuersten (Fitchburg, WI)
Assignee: Applied Biosystems, LLC
C12Q1/6855C12N15/1096C12Q1/68C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,191
App. No.
15/803,609
Granted
Mar 26, 2019
Kind
B2
Abstract

Compositions, methods, and kits for detecting one or more species of RNA molecules are disclosed. In one embodiment, a first adaptor and a second adaptor are ligated to the RNA molecule using a polypeptide comprising double-strand specific RNA ligase activity, without an intervening purification step. The ligated product is reverse transcribed, then at least some of the ribonucleosides in the reverse transcription product are removed. Primers are added and amplified products are generated. In certain embodiments, the sequence of at least part of at least one species of amplified product is determined and at least part of the corresponding RNA molecule is determined. In some embodiments, at least some of the amplified product species are detected, directly or indirectly, allowing the presence and/or quantity of the RNA molecule of interest to be determined.

Claims (42)

1. A composition, comprising: a single reaction mixture containing

a plurality of RNA molecules,

a plurality of a first double-stranded nucleic acid adaptor,

a plurality of a second double-stranded nucleic acid adaptor, and

a double-strand specific RNA ligase,

wherein a first strand of the first double-stranded nucleic acid adaptor of the plurality includes at least two ribonucleosides at the 3′ end, and a second strand of the first double-stranded nucleic acid adaptor of the plurality include a first single-stranded portion at the 5′ end, and

wherein a first strand of the second double-stranded nucleic acid adaptor of the plurality includes a terminal 5′ phosphate group, and a second strand of the second double-stranded nucleic acid adaptor of the plurality include a second single-stranded portion at the 3′ end, and

wherein the first single-stranded portion contains a degenerate nucleotide sequence that hybridizes to a first region of a first RNA molecule in the plurality of RNA molecules, and

wherein the second single-stranded portion contains a degenerate nucleotide sequence that hybridizes to a second region of the first RNA molecule in the plurality of RNA molecules.

2. The composition of claim 1 , wherein the RNA ligase comprises a T4 RNA ligase 2 (Rnl2).

3. The composition of claim 1 , wherein the single reaction mixture contains a single type of RNA ligase.

4. The composition of claim 1 , wherein

the second strand of the first double-stranded nucleic acid adaptors comprises at least one ribonucleotide, or

the second strand of the second double-stranded nucleic acid adaptors comprises at least one ribonucleotide, or

the second strand of the first double-stranded nucleic acid adaptors and the second strand of the second double-stranded nucleic acid adaptors comprise at least one ribonucleotide.

5. The composition of claim 1 , wherein

the plurality of the first double-stranded nucleic acid adaptor comprises a unique sample-specific bar code sequence, or

the plurality of the second double-stranded nucleic acid adaptor comprises a unique sample-specific bar code sequence, or

the plurality of the first and the second double-stranded nucleic acid adaptor comprise a different unique sample-specific bar code sequence.

6. The composition of claim 1 , wherein

the plurality of the first double-stranded nucleic acid adaptor comprises a reporter group, or

the plurality of the second double-stranded nucleic acid adaptor comprises a reporter group, or

the plurality of the first and the second double-stranded nucleic acid adaptor comprise a different reporter group.

7. The composition of claim 6 , wherein the reporter group comprises a fluorescent reporter group.

8. The composition of claim 6 , wherein the reporter group comprises biotin.

9. The composition of claim 1 , wherein

the plurality of the first double-stranded nucleic acid adaptor comprises a binding site for an amplification primer, or

the plurality of the second double-stranded nucleic acid adaptor comprises a binding site for an amplification primer, or

the plurality of the first and the second double-stranded nucleic acid adaptor comprise a binding site for a different amplification primer.

10. The composition of claim 1 , further comprising: a DNA polymerase having both a DNA-dependent DNA polymerase activity and RNA-dependent DNA polymerase activity.

11. The composition of claim 1 , further comprising:

an RNA-dependent DNA polymerase, or

an RNA-dependent DNA polymerase and a DNA-dependent DNA polymerase.

12. The composition of claim 1 , further comprising: RNaseH.

13. The composition of claim 1 , wherein the plurality of RNA comprises total RNA.

14. The composition of claim 1 , wherein the plurality of RNA comprises mRNA.

15. The composition of claim 1 , wherein the plurality of RNA comprises enriched RNA.

16. The composition of claim 15 , wherein the enriched RNA comprises polyA+RNA.

17. The composition of claim 1 , wherein the plurality of RNA comprises RNA that is depleted of an undesirable subset of RNA.

18. The composition of claim 1 , wherein the plurality of RNA comprises fragmented RNA.

19. The composition of claim 1 , wherein the plurality of RNA comprises RNA pooled from different samples.

20. The composition of claim 1 , further comprising a plurality of internal control RNA molecules having known sequences.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2018
From: KUERSTEN, SCOTT R.
To: APPLIED BIOSYSTEMS LLC
Reel/Frame 045655/0212 →
Continuity (12)
Division 15450675 · Mar 6, 2017
Division 15209090 · Jul 13, 2016
Division 14571142 · Dec 15, 2014
Continuation 13960780 · Aug 6, 2013
Continuation 13463758 · May 3, 2012
Continuation 12835869 · Jul 14, 2010
Continuation PCTUS2009030822 · Jan 13, 2009
Provisional Application 61020913 · Jan 14, 2008
Provisional Application 61034833 · Mar 7, 2008
Provisional Application 61039460 · Mar 26, 2008
Provisional Application 61047549 · Apr 24, 2008
Related Publication 20180051328A1 · Feb 22, 2018
Cited By (3)
US 12,540,321 US 12,637,670 US 12,686,864